Propanc Biopharma, Inc. Common Stock (PPCB) — Financial Flexibility Index
Propanc Biopharma, Inc. Common Stock (PPCB) has a Financial Flexibility Index of -0.25x as of March 2026. Free cash flow of $-1.14 Million (operating CF $-1.14 Million minus capex $4.77K) represents 0% of total liabilities ($4.51 Million). Check Propanc Biopharma, Inc. Common Stock investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Propanc Biopharma, Inc. Common Stock Financial Flexibility Index (2010–2025)
Historical Financial Flexibility Index trend for Propanc Biopharma, Inc. Common Stock across 16 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Propanc Biopharma, Inc. Common Stock.
Annual Financial Flexibility Index for Propanc Biopharma, Inc. Common Stock (2010–2025)
Year-by-year free cash flow to debt coverage for Propanc Biopharma, Inc. Common Stock. Explore PPCB operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.07x | $-405.17K | $-405.17K | $5.73 Million | ▲ +70.9% |
| 2024 | -0.24x | $-935.12K | $-935.12K | $3.85 Million | ▲ +30.2% |
| 2023 | -0.35x | $-1.11 Million | $-1.11 Million | $3.18 Million | ▲ +24.8% |
| 2022 | -0.46x | $-1.44 Million | $-1.44 Million | $3.11 Million | ▼ -24.4% |
| 2021 | -0.37x | $-1.15 Million | $-1.15 Million | $3.08 Million | ▲ +24.8% |
| 2020 | -0.49x | $-1.85 Million | $-1.85 Million | $3.74 Million | ▼ -5.8% |
| 2019 | -0.47x | $-2.06 Million | $-2.06 Million | $4.40 Million | — |
| 2018 | 0.00x | $0.00 | $-2.18 Million | $6.82 Million | ▲ +100.0% |
| 2017 | -0.39x | $-2.15 Million | $-2.15 Million | $5.54 Million | ▲ +76.1% |
| 2016 | -1.63x | $-4.79 Million | $-4.80 Million | $2.94 Million | ▼ -320.9% |
| 2015 | -0.39x | $-1.42 Million | $-1.43 Million | $3.68 Million | ▼ -159.8% |
| 2014 | -0.15x | $-226.44K | $-226.44K | $1.52 Million | ▲ +8.2% |
| 2013 | -0.16x | $-128.64K | $-128.65K | $794.22K | ▲ +44.4% |
| 2012 | -0.29x | $-170.28K | $-170.28K | $584.19K | ▲ +93.6% |
| 2011 | -4.54x | $-1.39 Million | $-1.40 Million | $306.85K | ▼ -446.6% |
| 2010 | -0.83x | $-191.51K | $-191.51K | $230.76K | — |